malondialdehyde has been researched along with chiisanoside in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bian, X; Li, H; Li, P; Liu, J; Wang, S; Zhang, L; Zhao, Y | 1 |
Bian, X; Gao, Y; Li, H; Li, P; Liu, J; Liu, X; Zhang, L; Zhao, Y | 1 |
2 other study(ies) available for malondialdehyde and chiisanoside
Article | Year |
---|---|
Hepatoprotective effect of chiisanoside against acetaminophen-induced acute liver injury in mice.
Topics: Acetaminophen; Alanine Transaminase; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspartate Aminotransferases; Catalase; Chemical and Drug Induced Liver Injury; Glutathione; Liver; Male; Malondialdehyde; Mice, Inbred ICR; NF-kappa B; Oligosaccharides; Oxidative Stress; Protective Agents; Superoxide Dismutase; Triterpenes; Tumor Necrosis Factor-alpha | 2019 |
Hepatoprotective effect of chiisanoside from Acanthopanax sessiliflorus against LPS/D-GalN-induced acute liver injury by inhibiting NF-κB and activating Nrf2/HO-1 signaling pathways.
Topics: Animals; Antioxidants; Chemical and Drug Induced Liver Injury; Drugs, Chinese Herbal; Eleutherococcus; Galactosamine; Glutathione; Heme Oxygenase-1; Humans; Lipopolysaccharides; Liver; Male; Malondialdehyde; Mice; Mice, Inbred ICR; NF-E2-Related Factor 2; NF-kappa B; Oligosaccharides; Protective Agents; Signal Transduction; Superoxide Dismutase; Triterpenes | 2019 |